Non-Small Cell Lung Cancer
EntreMed commences clinical trial for MKC-1 in lung cancer patients
Published in Women's Health Weekly, November 30th, 2006
The lead institution for this Phase 1/2, open label, dose escalation study will be the Indiana University Cancer Center in Indianapolis, Indiana. Nasser H. Hanna, MD, assistant professor, Department of Medicine, Division of Hematology/Oncology at IUCCI, will serve as principal investigator. MKC-1 is being evaluated currently in Phase 1 and 2 clinical studies against breast cancer and in patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cancer Prevention
Women are catching up to men in lung cancer deaths - Hormone Therapy
Hormone therapy does not improve quality of life for women, study indicates - Breast Cancer
New breast cancer study findings have been reported by researchers at Boston University, Department of Surgery - Breast Cancer
Research on breast cancer described by scientists at University of Glasgow, Department of Surgery - Breast Cancer
Studies from Cancer Center further understanding of breast cancer - Breast Cancer Cytology
Studies from Swedish Cancer Institute, Department of Surgery have provided new data on breast cancer cytology - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
